Percutaneous Mitral Valve Edge-to-Edge Repair for Degenerative Mitral Regurgitation

被引：3
作者：
Dal-Bianco J.P. [1 ]
Inglessis I. [1 ]
Melnitchouk S. [2 ]
Daher M. [1 ]
Palacios I.F. [1 ]
机构：
[1] Cardiology Division, Department of Medicine, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Yawkey 5B, Boston, 02114, MA
[2] Division of Cardiac Surgery, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, 02114, MA
来源：
Current Treatment Options in Cardiovascular Medicine | 2015年 / 17卷 / 7期
关键词：
MitraClip; Mitral regurgitation; Mitral valve; Percutaneous; TMVR; Transcatheter;
D O I：
10.1007/s11936-015-0389-7
中图分类号：
学科分类号：
摘要：
Surgical mitral valve (MV) repair remains the gold standard to treat patients with significant degenerative mitral regurgitation (DMR). Medical therapy was the only option for patients found to be not appropriate for MV surgery until the development of percutaneous/transcatheter MV repair options that now allow to reduce MR less invasively and safely. This article discusses the basic mechanisms of MR and the rationale for MR intervention and offers a detailed review on percutaneous/transcatheter MV repair with the MitraClip. © 2015, Springer Science+Business Media New York.
引用
收藏
页数：13
相关论文
共 48 条
[21]  
Condado J.A., Acquatella H., Rodriguez L., Whitlow P., Velez-Gimo M., Goar F.G.S., Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case, Catheter Cardiovasc Interv, 67, 2, pp. 323-325, (2006)
[22]  
Feldman T., Foster E., Glower D.D., Kar S., Rinaldi M.J., Fail P.S., Et al., Percutaneous repair or surgery for mitral regurgitation, N Engl J Med, 364, 15, pp. 1395-1406, (2011)
[23]  
Feldman T., Kar S., Rinaldi M., Fail P., Hermiller J., Smalling R., Et al., Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort, J Am Coll Cardiol, 54, 8, pp. 686-694, (2009)
[24]  
Mauri L., Foster E., Glower D.D., Apruzzese P., Massaro J.M., Herrmann H.C., Et al., 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation, J Am Coll Cardiol, 62, 4, pp. 317-328, (2013)
[25]  
Reichenspurner H., Schillinger W., Baldus S., Hausleiter J., Butter C., Schaefer U., Et al., Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip(R) device in the ACCESS-EUrope Phase I trial, Eur J Cardiothorac Surg, 44, 4, pp. e280-e288, (2013)
[26]  
Lim D.S., Reynolds M.R., Feldman T., Kar S., Herrmann H.C., Wang A., Et al., Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair, J Am Coll Cardiol, 64, 2, pp. 182-192, (2014)
[27]  
Taramasso M., Maisano F., Denti P., Latib A., La Canna G., Colombo A., Et al., Percutaneous edge-to-edge repair in high-risk and elderly patients with degenerative mitral regurgitation: midterm outcomes in a single-center experience, J Thorac Cardiovasc Surg, 148, 6, pp. 2743-2750, (2014)
[28]  
Lubos E., Schluter M., Vettorazzi E., Goldmann B., Lubs D., Schirmer J., Et al., MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome, JACC Cardiovasc Interv, 7, 4, pp. 394-402, (2014)
[29]  
Siegel R.J., Biner S., Rafique A.M., Rinaldi M., Lim S., Fail P., Et al., The acute hemodynamic effects of MitraClip therapy, J Am Coll Cardiol, 57, 16, pp. 1658-1665, (2011)
[30]  
Grayburn P.A., Foster E., Sangli C., Weissman N.J., Massaro J., Glower D.G., Et al., Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy, Circulation, 128, 15, pp. 1667-1674, (2013)
12345